QTL associated with SGC/Knj cross B6 QTL 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (133341830)
Authors:
Hamano Y, Tsukamoto K, Abe M, Sun GD, Zhang D, Fujii H, Matsuoka S, Tanaka M, Ishida-Okawara A, Tachikawa H, Nishimura H, Tokunaka K, Hirose S, Suzuki K
QTL associated with neurotensin transcript abundance 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (24071806)
QTL associated with systematic lupus erythematosus susceptibility 10. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (19802051)
Authors:
Haywood ME, Hogarth MB, Slingsby JH, Rose SJ, Allen PJ, Thompson EM, Maibaum MA, Chandler P, Davies KA, Simpson E, Walport MJ, Morley BJ
QTL associated with anti-dsDNA antibody production in NZM 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (100072102)
Authors:
Waters ST, Fu SM, Gaskin F, Deshmukh US, Sung SS, Kannapell CC, Tung KS, McEwen SB, McDuffie M
QTL associated with gastritis type A susceptibility locus 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (136704604)
Authors:
Baxter AG, Jordan MA, Silveira PA, Wilson WE, Van Driel IR
QTL associated with insulin dependent diabetes susceptibility 9. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (124439115)
Authors:
Cox SL, Stolp J, Hallahan NL, Counotte J, Zhang W, Serreze DV, Basten A, Silveira PA
QTL associated with circadian period of locomotor activity 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (26691206)
Authors:
Mayeda AR, Hofstetter JR, Belknap JK, Nurnberger JI Jr
QTL associated with amphetamine distance traveled 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (20861477)
Authors:
Torkamanzehi A, Boksa P, Ayoubi M, Fortier ME, Ng Ying Kin NM, Skamene E, Rouleau G, Joober R
QTL associated with darker modification of yellow agouti QTL 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (45435458)
QTL associated with granulosa cell tumorigenesis 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (144647559)
Authors:
Dorward AM, Shultz KL, Horton LG, Li R, Churchill GA, Beamer WG
QTL associated with recognized antigen from MCA-induced tumor 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (133923341)
QTL associated with beta-carboline-induced seizures 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (136693037)
QTL associated with CD4 virgin T cell subset 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (102244246)
QTL associated with "lupus in MRL and B6 F2 cross, QTL 1". This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (124048407)
Authors:
Santiago-Raber ML, Haraldsson MK, Theofilopoulos AN, Kono DH
QTL associated with phospholipid transfer protein inducibility QTL 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (141449885)
Authors:
Korstanje R, Albers JJ, Wolfbauer G, Li R, Tu AY, Churchill GA, Paigen BJ
QTL associated with triglyceride level suppressor 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (127039007)
Authors:
Shike T, Hirose S, Kobayashi M, Funabiki K, Shirai T, Tomino Y
QTL associated with bone response to mechanical loading 10. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (123838543)
GeneWeaver